Sonova H Ag Total Assets

Latest as of March 2026: CHF5.63 Billion CHF ≈ $7.12 Billion USD

Sonova H Ag total assets. Based on the latest financial reports, Sonova H Ag (SOON) holds total assets worth CHF5.63 Billion CHF (≈ $7.12 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Sonova H Ag for the company's overall valuation and market capitalisation.

Total Assets of Sonova H Ag (2002–2026)

Total assets of Sonova H Ag from 2002 to 2026. This chart illustrates how Sonova H Ag's total assets have evolved over time, based on quarterly financial data. See latest Sonova H Ag stock price today for real-time trading data and today's change.

Sonova H Ag - Asset Composition Analysis

Sonova H Ag Total Assets Breakdown (March 2026)

Sonova H Ag total assets breakdown as of March 2026. Sonova H Ag's total assets of CHF5.63 Billion consist of 37.0% current assets and 63.0% non-current assets.

Asset Category Amount (CHF) % of Total Assets
Cash & Equivalents CHF0.00 12.8%
Accounts Receivable CHF665.10 Million 11.8%
Inventory CHF381.00 Million 6.8%
Property, Plant & Equipment CHF0.00 0.0%
Intangible Assets CHF112.90 Million 2.0%
Goodwill CHF2.28 Billion 40.6%

Asset Composition Trend (2002–2026)

This chart illustrates how Sonova H Ag's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore SOON working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Sonova H Ag's current assets represent 37.0% of total assets in 2026, a decrease from 41.3% in 2002.
  • Cash Position: Cash and equivalents constituted 12.8% of total assets in 2026, up from 9.8% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 32.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 40.6% of total assets.

Sonova H Ag Competitors by Total Assets

Key competitors of Sonova H Ag based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
GN Store Nord
CO:GN
Denmark Dkr29.23 Billion
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
China CN¥1.86 Billion
Polynovo Ltd
AU:PNV
Australia AU$123.37 Million
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
VIROMED MEDICAL NA O.N.
XETRA:VME
Germany €13.91 Million
Affluent Medical SAS
PA:AFME
France €59.84 Million
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

Sonova H Ag - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.75 1.27 2.09
Quick Ratio 1.43 0.96 1.85
Cash Ratio 0.00 0.46 1.41
Working Capital CHF895.10 Million CHF411.20 Million CHF1.37 Billion

Sonova H Ag - Advanced Valuation Insights

This section examines the relationship between Sonova H Ag's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.75
Latest Market Cap to Assets Ratio 2.17
Asset Growth Rate (YoY) -5.0%
Total Assets CHF5.63 Billion
Market Capitalization $12.20 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Sonova H Ag's assets at a significant premium (2.17x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Sonova H Ag's assets decreased by 5.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Sonova H Ag (2002–2026)

The table below shows the annual total assets of Sonova H Ag from 2002 to 2026.

Year Total Assets Change
2026-03-31 CHF5.63 Billion
≈ $7.12 Billion
-4.99%
2025-03-31 CHF5.92 Billion
≈ $7.49 Billion
+2.29%
2024-03-31 CHF5.79 Billion
≈ $7.32 Billion
+4.31%
2023-03-31 CHF5.55 Billion
≈ $7.02 Billion
-0.64%
2022-03-31 CHF5.59 Billion
≈ $7.06 Billion
-5.69%
2021-03-31 CHF5.93 Billion
≈ $7.49 Billion
+32.08%
2020-03-31 CHF4.49 Billion
≈ $5.67 Billion
+4.52%
2019-03-31 CHF4.29 Billion
≈ $5.43 Billion
-0.22%
2018-03-31 CHF4.30 Billion
≈ $5.44 Billion
+9.31%
2017-03-31 CHF3.94 Billion
≈ $4.98 Billion
+43.03%
2016-03-31 CHF2.75 Billion
≈ $3.48 Billion
+2.23%
2015-03-31 CHF2.69 Billion
≈ $3.40 Billion
+3.77%
2014-03-31 CHF2.59 Billion
≈ $3.28 Billion
-3.25%
2013-03-31 CHF2.68 Billion
≈ $3.39 Billion
+17.21%
2012-03-31 CHF2.29 Billion
≈ $2.89 Billion
+5.32%
2011-03-31 CHF2.17 Billion
≈ $2.75 Billion
-9.86%
2010-03-31 CHF2.41 Billion
≈ $3.05 Billion
+68.89%
2009-03-31 CHF1.43 Billion
≈ $1.80 Billion
+12.06%
2008-03-31 CHF1.27 Billion
≈ $1.61 Billion
+0.76%
2007-03-31 CHF1.26 Billion
≈ $1.60 Billion
+36.12%
2006-03-31 CHF928.12 Million
≈ $1.17 Billion
+24.86%
2005-03-31 CHF743.36 Million
≈ $939.81 Million
+8.65%
2004-03-31 CHF684.21 Million
≈ $865.02 Million
+12.74%
2003-03-31 CHF606.86 Million
≈ $767.24 Million
-18.24%
2002-03-31 CHF742.25 Million
≈ $938.40 Million
--

About Sonova H Ag

SW:SOON Switzerland Medical Devices
Market Cap
$21.31 Billion
CHF16.86 Billion CHF
Market Cap Rank
#1843 Global
#34 in Switzerland
Share Price
CHF283.80
Change (1 day)
+0.78%
52-Week Range
CHF168.05 - CHF283.80
All Time High
CHF379.39
About

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service … Read more